A detailed history of Greystone Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Greystone Financial Group, LLC holds 256,521 shares of PFE stock, worth $6.85 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares
256,521
Previous 246,845 3.92%
Holding current value
$6.85 Million
Previous $6.91 Million 7.49%
% of portfolio
1.33%
Previous 1.37%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$27.7 - $31.39 $268,025 - $303,729
9,676 Added 3.92%
256,521 $7.42 Million
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $1.03 Million - $1.21 Million
40,879 Added 19.85%
246,845 $6.91 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $5.33 Million - $6.12 Million
205,966 New
205,966 $5.72 Million
Q3 2023

Nov 01, 2023

BUY
$32.09 - $37.51 $279,568 - $326,787
8,712 Added 7.93%
118,587 $3.93 Million
Q2 2023

Jul 18, 2023

SELL
$36.12 - $41.79 $2.09 Million - $2.41 Million
-57,740 Reduced 34.45%
109,875 $4.03 Million
Q1 2023

Apr 25, 2023

SELL
$39.39 - $51.28 $313,898 - $408,650
-7,969 Reduced 4.54%
167,615 $6.84 Million
Q4 2022

Jan 23, 2023

SELL
$41.75 - $54.5 $66,591 - $86,927
-1,595 Reduced 0.9%
175,584 $0
Q3 2022

Oct 25, 2022

SELL
$43.76 - $53.42 $175,390 - $214,107
-4,008 Reduced 2.21%
177,179 $7.75 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $8.43 Million - $10 Million
181,187 New
181,187 $9.5 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $5.19 Million - $5.85 Million
-155,010 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $5.19 Million - $6.6 Million
155,010 New
155,010 $5.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Greystone Financial Group, LLC Portfolio

Follow Greystone Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greystone Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greystone Financial Group, LLC with notifications on news.